摘要 |
<p>Disclosed are methods for treating various cancers. Methods encompass the administration of an mTOR inhibitor in combination with a second drug selected from an ImiD, a PDE4 inhibitor, a p38 MAP kinase inhibitor, a xanthine anticytokine, a dual TACE/MMP inhibitor and a proteasome inhibitor. The methods are aimed at providing a desirable therapeutic window while maintaining prior, if not higher, dose levels of the mTOR inhibitor.</p> |
申请人 |
ARIAD GENE THERAPEUTICS, INC.;SONIS, STEPHEN, T.;BEDROSIAN, CAMILLE, L. |
发明人 |
SONIS, STEPHEN, T.;BEDROSIAN, CAMILLE, L. |